HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AGREE AND HALSA LEAD DEP THIRD QUARTER SALES GROWTH

This article was originally published in The Rose Sheet

Executive Summary

AGREE AND HALSA LEAD DEP THIRD QUARTER SALES GROWTH, generating $9.7 mil. in the three months ended April 30, or over one-fourth of the company's sales of $35.1 mil., which were ahead 25%, Dep said June 7. L.A. Looks "improved slightly," Dep noted. "While Agree and Halsa were the primary contributors to overall sales growth," the firm stated, "the brands' sales for the quarter were still lower than anticipated prior to their acquisition from S.C. Johnson & Son Inc. in August 1993."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel